Author

T. E. Morrison

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:mouse· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

B. J. Davenport· 3 shared C. J. Lucas· 2 shared F. S. Li· 2 shared K. S. Carpentier· 2 shared M. G. Parks· 2 shared M. K. McCarthy· 2 shared A. Bosco-Lauth· 1 shared A. Catala· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. J. Davenport

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2

B. C. Ware, M. G. Parks, T. E. Morrison

This study shows that Chikungunya virus (CHIKV) nonstructural protein 2 (nsP2) disrupts MHC-I antigen presentation in infected fibroblasts, enabling immune evasion.

bioRxiv · Nov 3, 2023Immunology

Phagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner.

S. E. Ander, M. G. Parks, B. J. Davenport, F. S. Li, A. Bosco-Lauth, K. S. Carpentier, C. Sun, C. J. Lucas, W. B. Klimstra, G. D. Ebel, T. E. Morrison

This study shows that phagocyte-expressed glycosaminoglycans mediate species-specific vascular clearance of alphaviruses, with some viruses being cleared faster than others.

bioRxiv · Aug 9, 2023Microbiology

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease

B. J. Davenport, A. Catala, S. M. Weston, R. M. Johnson, J. Ardunay, H. L. Hammond, C. Dillen, M. B. Frieman, C. E. Catalano, T. E. Morrison

This paper develops a phage-like particle vaccine platform that is immunogenic and protects against SARS-CoV-2 and MERS-CoV infection and disease.

bioRxiv · Nov 8, 2021Immunology

MARCO+ lymphatic endothelial cells sequester arboviruses to limit viremia and viral dissemination

K. S. Carpentier, R. M. Sheridan, C. J. Lucas, B. J. Davenport, F. S. Li, E. D. Lucas, M. K. McCarthy, G. V. Reynoso, N. A. May, B. A. Tamburini, J. R. Hesselberth, H. D. Hickman, T. E. Morrison

This study identifies MARCO+ lymphatic endothelial cells as key in limiting arboviral viremia by sequestering alphavirus particles in draining lymph nodes and the liver.

bioRxiv · Jun 10, 2021Immunology

Fast and scalable lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro

G. Wang, H. Gaikwad, M. K. McCarthy, M. Gonzalez-Juarrero, Y. Li, M. Armstrong, N. Reisdorf, T. E. Morrison, D. Simberg

bioRxiv · Dec 18, 2020Pharmacology & Toxicology